文章核心观点 - 美敦力产品公司自愿召回五批小秘方蜂蜜止咳糖浆，原因是产品存在蜡样芽孢杆菌且保质期稳定性丧失，公司将为购买召回批次产品的消费者提供报销 [1][8] 召回产品信息 - 召回产品为小秘方蜂蜜止咳糖浆，包装为4液量盎司（118毫升）琥珀色瓶子，装在外部纸盒中，批次代码同时出现在瓶身标签和纸盒底部，不包括其他小秘方产品 [4] - 受影响批次产品于2022年12月14日至2025年6月4日通过零售商和在线渠道在美国全国范围内分销 [2] - 召回产品的UPC、批次号和保质期分别为：UPC 7 - 56184 - 10737 - ，批次号0039 0545，保质期11/2025 01/2026；UPC 9，批次号0640，保质期02/2026；批次号0450，保质期05/2026；批次号1198，保质期12/2026 [3] 产品危害 - 蜡样芽孢杆菌可导致两种食源性疾病，一种在食用受污染食物1至6小时后出现恶心、呕吐和胃痉挛，另一种在8至16小时后出现胃痉挛和腹泻，腹泻量可能少或大量水样，健康个体可能仅患短期疾病，但高剂量暴露可导致死亡 [1] 处理建议 - 消费者若有召回产品应立即停止使用，若出现可能与使用该产品有关的问题应联系医生或医疗服务提供者 [8] - 消费者可通过电子邮件medicalaffairs@prestigebrands.com、网站https://www.prestigebrands.com/contact或电话(800) 754 - 8853（周一至周五东部时间8:30 - 17:30）联系美敦力咨询退款或相关问题 [9] - 产品使用中的不良反应或质量问题可向FDA的MedWatch不良事件报告计划报告，方式有在线、普通邮件或传真 [9] 其他信息 - 截至目前未报告严重不良事件，此次召回在FDA知情下进行 [8][10] - 公告附带照片可在https://www.globenewswire.com/NewsRoom/AttachmentNg/ca32fb6c - 5efc - 4785 - bf61 - 239d42d91bfb和https://www.globenewswire.com/NewsRoom/AttachmentNg/fca77e04 - 87d0 - 45ef - b10e - 7b13ae6e4adc查看 [10] - 在线提交报告网址为www.fda.gov/medwatch/report.htm，普通邮件或传真需下载表格www.fda.gov/MedWatch/getforms.htm或致电1 - 800 - 332 - 1088索取报告表格，填好后按预填地址返回或传真至1 - 800 - FDA - 0178 [10]

Prestige Consumer Healthcare (PBH) FY Conference June 11, 2025 10:30 AM ET Speaker0 Good morning, everyone, and thank you for joining us at Oppenheimer's twenty fifth Annual Consumer Growth and Ecommerce Conference. My name is Rupesh Parikh. I'm the senior food, grocery, and consumer products analyst here at Oppenheimer. I'm happy to introduce our next presenting company, Prestige Consumer Healthcare. Joining us today are CEO, Ron Lombardi and VP, IR, and Treasury, Phil Turpolili. Prestige sells and distrib ...

Safe Harbor Disclosure This presentation contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding the Company's expected financial performance, including revenues, organic revenue growth, diluted EPS, and free cash flow; the Company's reinvestment in Clear Eyes as supply increases; the Company's ability to execute on its brand- building strategy and to drive free cash flow and maximize shareholder value; e-commerce ...

Key Takeaways PBH gains from digital strategies, e-commerce momentum and niche brand innovations like Hydralyte. Acquisitions and product diversity help PBH minimize category-specific slowdowns and market volatility. Long-term debt of $1.01B and forex risks challenge PBH's profitability despite solid revenue growth forecasts.Prestige Consumer Healthcare’s (PBH) long-term growth strategy centers on building great brands. The company continues to experience robust momentum in the e-commerce channel as a res ...

Prestige Consumer (PBH) has witnessed strong momentum in the past year. Shares of the company have risen 35.7% compared with 7.9% growth of the industry during the same time frame. The S&P 500 composite has increased 9.3%.With healthy fundamentals and strong growth opportunities, this Zacks Rank #2 (Buy) company appears to be a solid wealth creator for its investors at the moment.Prestige Consumer develops, manufactures, markets, sells and distributes over-the-counter (OTC) healthcare and household cleaning ...

Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and EssilorLuxottica Unsponsored ADR (ESLOY) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank is ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to ____________ Commission file number: 001-32433 PRESTIGE CONSUMER HEALTHCARE INC. (Exact name of registrant as specified in its charter) Delaware 20-12975 ...

Prestige Consumer Healthcare (PBH) Q4 2025 Earnings Call May 08, 2025 08:30 AM ET Company Participants Phil Terpolilli - Vice President of Investor Relations & TreasurerRonald Lombardi - Chairman, President & CEOChristine Sacco - CFO & COOKeith D - Vice PresidentDouglas Lane - Head of Consumer Products Conference Call Participants Rupesh Parikh - Managing Director and Senior AnalystSusan Anderson - Managing Director & Senior AnalystNone - AnalystAnthony Lebiedzinski - Senior Equity Research Analyst Operator ...

Prestige Consumer Healthcare (PBH) Q4 2025 Earnings Call May 08, 2025 08:30 AM ET Speaker0 and thank you for standing by. Welcome to the Prestige Consumer Healthcare's Fourth Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Phil Turpoli, Vice ...

Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.32 per share, beating the Zacks Consensus Estimate of $1.30 per share. This compares to earnings of $1.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 1.54%. A quarter ago, it was expected that this medicine distributor would post earnings of $1.16 per share when it actually produced earnings of $1.22, delivering a surprise of 5.17%.Over the last four ...